Press Releases

Hogan Lovells represents Intellia Therapeutics in life sciences collaboration to create new T-Cell therapy company

Munich, 16 July 2021 – Global law firm Hogan Lovells represents Intellia Therapeutics in the launch of a new autologous and allogeneic universal chimeric antigen receptor (CAR) T-cell...

Press Releases

Hogan Lovells advises Myriad Genetics on the sale of the private clinic Dr. Robert Schindlbeck

Led by Munich partner Peter Huber and counsel Andreas Thun, Hogan Lovells advised Myriad Genetics on the sale of the private clinic Dr. Robert Schindlbeck in Herrsching to the district of...

Press Releases

Hogan Lovells advises MorphoSys on global licensing and development of blood cancer drug tafasitamab

Led by its partners Jörg Schickert and Arne Thiermann, and in close collaboration with MorphoSys in-house deal counsel Virginie Galitschke, international law firm Hogan Lovells has...

Press Releases

Hogan Lovells advises ESTEVE on the acquisition of Riemser

Led by partners Daniel Dehghanian and Jörg Schickert international law firm Hogan Lovells has advised Barcelona-based, global pharmaceutical company ESTEVE on its acquisition of German ...

Press Releases

Hogan Lovells advises Vifor Pharma on establishment of joint venture with Evotec for early stage development in nephrology

Led by Munich partner Michael Rose, Hogan Lovells has advised the Swiss pharmaceutical company Vifor Pharma on the establishment of a joint venture with Evotec focusing on the research and...

Loading data